Intrinsic Value

The intrinsic value of Justera Health Ltd (VTAL) under the Base Case is 0.003 CAD per share. Compared with the current market price of 0.005 CAD, the stock appears Overvalued by 46% .

The intrinsic value is calculated using the DCF method. Operating margin recovers from -200% last year to 12% by 2031. Revenue grows about -17% a year over the next five years.

Do our valuations actually work? See backtest results .

VTAL Intrinsic Value
CA$0.003
Overvaluation 46%
Intrinsic Value
Price CA$0.005
Alert me when VTAL is below its intrinsic value
Today CA$0.002 · 57.0% below the current price

VTAL is more expensive than usual. It was this expensive or more expensive on just 16% of days in the past 5 years.

Alternatives to VTAL

Fundamental Analysis

What Justera Health Does

Justera Health Ltd. provides coronavirus screening software and services. The company is headquartered in Toronto, Ontario. The company went IPO on 2021-03-05. The company offers personalized healthcare services and solutions, such as IV Vitamin Therapy, premium nutritional supplements through its Naturevan Nutrition brand, a full 360-degree wellness and spa experience through Juillet Wellness that provides registered massage therapy, acupuncture, and new retail stores in Vancouver.

Headquarters
Canada CA
IPO date
Mar 5, 2021
Read the full company overview
View Company Overview
Financials

Revenue & Expenses Breakdown
Justera Health Ltd

Efficiency

Earnings Waterfall
Justera Health Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one VTAL stock?

The intrinsic value for Justera Health Ltd (VTAL) under the Base Case is 0.003 CAD.

Is VTAL stock undervalued or overvalued?

Compared with the current market price of 0.005 CAD, the stock appears Overvalued by 46% .

Back to Top